sr141716 has been researched along with jwh-073 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Douglas, JT; Fantegrossi, WE; Ford, BM; Franks, LN; Prather, PL; Prisinzano, TE; Vasiljevik, T | 1 |
Ginsburg, BC; Hruba, L; McMahon, LR; Schulze, DR | 1 |
2 other study(ies) available for sr141716 and jwh-073
Article | Year |
---|---|
Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.
Topics: Alcoholism; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Conditioning, Classical; Cricetinae; Cricetulus; Drug Design; Drug Inverse Agonism; Ethanol; Humans; Indoles; Ligands; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Self Administration; Structure-Activity Relationship | 2013 |
JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Data Interpretation, Statistical; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Female; Hallucinogens; Illicit Drugs; Indoles; Macaca mulatta; Male; Marijuana Abuse; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome | 2012 |